Hologic Announces Financial Results for Second Quarter of Fiscal 2018
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Hologic (HOLX) PT Lowered to $40 at RBC Capital
May 3, 2018 8:47 AM EDTRBC Capital lowered its price target on Hologic (NASDAQ: HOLX) to $40.00 (from $44.00) while maintaining a Sector Perform rating.
... MoreHologic (HOLX) PT Lowered to $40.50 at Evercore ISI
May 3, 2018 7:37 AM EDTEvercore ISI lowered its price target on Hologic (NASDAQ: HOLX) to $40.50 (from $42.50) while maintaining a Outperform rating.
... MoreHologic (HOLX) PT Lowered to $43 at Needham & Company; 'Ugly Write-Down for Aesthetics Business'
May 3, 2018 6:43 AM EDTNeedham & Company lowered its price target on Hologic (NASDAQ: HOLX) to $43.00 (from $50.00) while maintaining a Buy rating.
Analyst Mike Matson commented, " HOLX's F2Q18 revenue beat and EPS met consensus. But management lowered its FY18 revenue guidance due to Cynosure and... More
Hologic (HOLX) Reports In-Line Q2 EPS; Lowers Rev Guidance, Maintains EPS
May 2, 2018 4:05 PM EDTHologic (NASDAQ: HOLX) reported Q2 EPS of $0.53, in-line with the analyst estimate of $0.53. Revenue for the quarter came in at $789.3 million versus the consensus estimate of $781.84 million.
GUIDANCE:
Hologic sees FY2018 revenue of $3.18-3.21 million, versus the consensus of $3.25... More
